Estudio de V937 en combinación con pembrolizumab en participantes con tumores sólidos avanzados/metastásicos
The purpose of this study is to evaluate the safety, tolerability, and efficacy in participants with advanced/metastatic or recurrent malignancies who receive V937 in Combination with Pembrolizumab (MK-3475). The primary objective